Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab and Azathioprine in Membranous Lupus Nephritis
NCT00368264Phase 3Terminated
- Sponsor
- Medical University of Vienna
- Start
- Sep 2006
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of infliximab in lupus membranous nephropathy (LMN), sponsored by Medical University of Vienna. Started Sep 2006; status: terminated.
02
Drugs
infliximab
03
Conditions
lupus membranous nephropathy (LMN)
Beyond the preview
Go deeper on NCT00368264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368264.